Inari Medical Investors: Company Investigated by the Portnoy Law Firm


Investors can contact the law firm at no cost to learn more about recovering their losses

​LOS ANGELES, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Inari Medical, Inc. (NASDAQ: NARI) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Inari stock. Inari investors are encouraged to contact the firm to discuss their legal rights.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

After the markets closed on February 28, 2024, Inari Medical revealed its financial results for the fourth quarter and the full year of 2023. In addition, the company announced that it had received a civil investigative demand from the US Department of Justice concerning an investigation under the federal Anti-Kickback Statute and Civil False Claims Act, related to specific payments made to healthcare professionals. Following this disclosure, shares of Inari Medical, Inc. experienced a significant decline, falling over 18% during intraday trading on February 29, 2024.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com

Attorney Advertising